HealthEquity (HQY) Releases Q1 2027 Earnings: Revenue and Gross Profit Rise, EPS Miss

HealthEquity Inc. (HQY) reported Q1 2027 results with total revenue of $354.6 million, up 7.2% year‑over‑year, slightly below the analyst estimate of $355.4 million.

Key income statement highlights:

Gross profit of $256.3 million (+14.3% YoY).

Operating profit of $103.0 million (+23.9% YoY).

Net income attributable to common shareholders of $69.4 million (+28.8% YoY).

Diluted earnings per share of $0.82 (+34.4% YoY).

Cash flow and balance sheet items:

Cash from operating activities of $97.5 million (+50.7% YoY).

Purchases of property, plant and equipment of $(362,000) (up 320.9% YoY).

Cash and cash equivalents of $265.4 million (down 7.8% YoY).

Total liabilities of $1.259 billion (down 2.6% YoY).

Cost of sales of $98.3 million (down 7.7% YoY).

How results compared with expectations:

Diluted EPS came in below the estimate of $1.13, at $0.82.

Revenue was slightly under the forecast of $355.4 million.

Overall, revenue and gross profit growth outpaced cost of sales, and operating profit expanded notably, pointing to margin improvement and stronger operating leverage in the quarter for HealthEquity Inc. (HQY).

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

HealthEquity Inc. Insider Trading Activity

HealthEquity Inc. insiders have traded $HQY stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $HQY stock by insiders over the last 6 months:

ELIMELECH ROSNER (EVP, CHIEF TECHNOLOGY OFFICER) sold 10,959 shares for an estimated $1,046,090
GAYLE FURGURSON WELLBORN sold 4,339 shares for an estimated $425,330
DELANO LADD (EVP, General Counsel) sold 1,500 shares for an estimated $142,080

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

HealthEquity Inc. Hedge Fund Activity

We have seen 257 institutional investors add shares of HealthEquity Inc. stock to their portfolio, and 313 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 1,855,208 shares (+inf%) to their portfolio in Q4 2025, for an estimated $169,955,604
INVESCO LTD. removed 1,257,352 shares (-59.1%) from their portfolio in Q4 2025, for an estimated $115,186,016
WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,239,604 shares (-63.5%) from their portfolio in Q1 2026, for an estimated $103,593,706
MORGAN STANLEY added 999,856 shares (+67.3%) to their portfolio in Q1 2026, for an estimated $83,557,965
FMR LLC removed 917,638 shares (-44.7%) from their portfolio in Q1 2026, for an estimated $76,687,007
BLACKROCK, INC. removed 683,435 shares (-6.1%) from their portfolio in Q1 2026, for an estimated $57,114,662
MACQUARIE GROUP LTD removed 633,143 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $58,002,230

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

HealthEquity Inc. Government Contracts

We have seen $28,377,182 of award payments to $HQY over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

THIS TASK ORDER IS ISSUED TO OFFSET (BUYDOWN) PART OF THE ADMINISTRATIVE FEE CHARGED TO AGENCIES FOR BENEFI...: $21,999,487
ADMINISTRATIVE SERVICE FEES FOR VA FSAFEDS PARTICIPANTS: $2,700,000
THIS TASK ORDER IS ISSUED TO OFFSET (BUYDOWN) PART OF THE ADMINISTRATIVE FEE CHARGED TO AGENCIES FOR BENEFI...: $1,559,344
THE FEDERAL FLEXIBLE SPENDING ACCOUNT PROGRAM (FSAFEDS): 2025 ADMINISTRATIVE FEES: $311,031
2024 FSAFEDS FLEXIBLE SPENDING: $114,863

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

HealthEquity Inc. Analyst Ratings

Wall Street analysts have issued reports on $HQY in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barrington Research issued a "Outperform" rating on 05/22/2026
BTIG issued a "Buy" rating on 12/04/2025
Citizens issued a "Market Outperform" rating on 12/04/2025

To track analyst ratings and price targets for HealthEquity Inc., check out Quiver Quantitative's $HQY forecast page.

HealthEquity Inc. Price Targets

Multiple analysts have issued price targets for $HQY recently. We have seen 10 analysts offer price targets for $HQY in the last 6 months, with a median target of $110.0.

Here are some recent targets:

Alexander Paris from Barrington Research set a target price of $110.0 on 05/22/2026
Sean Dodge from BMO Capital set a target price of $105.0 on 04/09/2026
George Hill from Deutsche Bank set a target price of $128.0 on 03/19/2026
Daniel R. Perlin from RBC Capital set a target price of $100.0 on 03/18/2026
Alexei Gogolev from JP Morgan set a target price of $123.0 on 03/18/2026
Glen Santangelo from Barclays set a target price of $110.0 on 02/18/2026
David Larsen from BTIG set a target price of $110.0 on 02/17/2026